New Covenant Trust Company’s Vanguard Intermediate-Term Bond ETF BIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$357K Buy
4,653
+134
+3% +$10.3K 0.27% 62
2026
Q1
$349K Hold
4,519
0.31% 55
2025
Q4
$352K Hold
4,519
0.32% 47
2025
Q3
$353K Hold
4,519
0.33% 48
2025
Q2
$348K Hold
4,519
0.31% 46
2025
Q1
$345K Buy
4,519
+1,494
+49% +$113K 0.36% 47
2024
Q4
$226K Buy
+3,025
New +$230K 0.22% 79
2024
Q2
Sell
-1,396
Closed -$105K 115
2024
Q1
$105K Buy
+1,396
New +$105K 0.11% 122

Other funds holding BIV

New Covenant Trust Company's BIV Position: Q2 2026 in Review

New Covenant Trust Company increased its Vanguard Intermediate-Term Bond ETF (BIV) stake by 3% in Q2 2026, buying an estimated $10.3K and bringing the position to 4,653 shares worth $357K. The position accounts for 0.27% of the portfolio, ranked #62.

New Covenant Trust Company first reported a position in BIV in Q1 2024 and has held it in 8 quarters since. 347 funds tracked by Wall St. Rank hold BIV as of Q2 2026.

  • New Covenant Trust Company held 4,653 shares of Vanguard Intermediate-Term Bond ETF worth $357K as of Q2 2026.
  • New Covenant Trust Company bought 134 Vanguard Intermediate-Term Bond ETF shares in Q2 2026, an estimated $10.3K.
  • Vanguard Intermediate-Term Bond ETF made up 0.27% of New Covenant Trust Company's portfolio in Q2 2026, its #62 holding.
  • New Covenant Trust Company first reported a position in Vanguard Intermediate-Term Bond ETF in Q1 2024 and has held it in 8 quarters since.
  • 347 funds tracked by Wall St. Rank held Vanguard Intermediate-Term Bond ETF as of Q2 2026.

Based on New Covenant Trust Company's 13F filing for Q2 2026, filed 14 Jul 2026.